Meniere’s disease is a condition in which there is an excess of fluid in the inner ear, which can produce symptoms such as vertigo, tinnitus and fluctuating hearing loss. According to Meniere’s Australia, it affects one in every 600 Australians.
Menière's disease is defined by the association of 4 symptoms: vertigo attacks, fluctuating hearing loss, tinnitus and an auricular plenitude sensation. The pathophysiology is commonly explained by a distension of membranous labyrinth by the endolymph, equally called endolymphatic hydrops. Recent studies also tend to relate the disease to immune mechanisms.
Out of the 39 patients assessed, 31 were females (79.5%). Patients ages when the symptoms started varied between 18 and 72 years, with average age of 42.9 years, with standard deviation of 13.3. Nineteen patients (48.7%) had between 41 and 64 years of age.
Treatment of MD is aimed primarily at control of vertigo attacks. All the procedures described below are mentioned from this perspective. While some patients note improvement in hearing as their vertigo improves, this is not predictable.Amplification therapy for the hearing loss of MD is outside the scope of this discussion.
Major research on disease:
Traditional thinking on the origin of Meniere's disease,Fortunately, fully digital aids, which limit overstimulation, are reasonably effective in ameliorating the effects of loudness recruitment while compensating for the elevated thresholds of the affected ear.